Loading…
CVRx, Inc. is projected to rise to $7.34 by 2027, a +35% move from its current price of $5.43. CVRX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $5.19 | $5.43 | $5.68 | 0.00% |
| Jul 13 | $5.09 | $5.43 | $5.79 | 0.00% |
| Jul 14 | $5.02 | $5.43 | $5.87 | 0.00% |
| Jul 15 | $4.96 | $5.43 | $5.94 | 0.00% |
| Jul 16 | $4.91 | $5.43 | $6.01 | 0.00% |
| Jul 17 | $4.86 | $5.43 | $6.07 | 0.00% |
| Jul 18 | $4.82 | $5.43 | $6.12 | 0.00% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.82 | $5.43 | $6.12 | 0.00% |
| Week 2 | $4.59 | $5.43 | $6.43 | 0.00% |
| Week 3 | $4.41 | $5.43 | $6.68 | +0.01% |
| Week 4 | $4.27 | $5.43 | $6.90 | +0.01% |
| Week 5 | $4.16 | $5.43 | $7.10 | +0.01% |
| Week 6 | $4.05 | $5.43 | $7.28 | +0.01% |
| Week 7 | $3.96 | $5.43 | $7.45 | +0.02% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CVRx, Inc. is a commercial-stage medical device company focused on neuromodulation solutions for cardiovascular diseases. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system.
CVRx sells its products through direct sales force, sales agents, and independent distributors. It was incorporated in 2000 and is headquartered in Minneapolis, Minnesota, with operations in the United States, Germany, and internationally.
CVRx, Inc. (CVRX) operates in the healthcare sector as a medical device company focused on neuromodulation for cardiovascular diseases. The current price is $5.27, and the market cap stands at $139.84M, with a market ranking of 4038.
The Barostim device and baroreflex activation therapy anchor its product portfolio, with a global reach that includes the United States, Germany, and other regions. The stock presents a price outlook derived from year-by-year forecasts, which show a path from neutral in 2026 toward bullish momentum in later years.
Forecasts show a steady long-term trajectory, with 2026 averaging $5.27 and rising to the mid-teens by the early 2030s, then into the tens of dollars by 2040 and beyond. These projections include notable upside potential, but remain estimates and are not guarantees of future results.
A major floor 21.0% below — a decisive break under it would weaken the trend.
The nearest floor, 11.0% below — buyers have tended to step in here.
The nearest ceiling, 9.4% above — a clean break opens room to run.
A major ceiling 74.2% above — clearing it would confirm fresh momentum.
Key CVRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CVRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.45 | Sell | $5.41 | Buy |
| MA 10 | $5.53 | Sell | $5.41 | Buy |
| MA 20 | $5.26 | Buy | $5.42 | Buy |
| MA 50 | $5.79 | Sell | $5.84 | Sell |
| MA 100 | $6.82 | Sell | $6.45 | Sell |
| MA 200 | $7.57 | Sell | $7.22 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.96 | Neutral |
| Stoch RSI (14) | 59.89 | Neutral |
| CCI (20) | 38.75 | Neutral |
| Williams %R (14) | -47.22 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | 5.44 | Buy |
| Bollinger %B (20,2) | 0.62 | Neutral |
| Stochastic %K (14) | 52.78 | Neutral |
| TRIX (15) | -0.32 | Sell |
| Awesome (5,34) | 0.06 | Buy |
| Ultimate (7,14,28) | 57.91 | Neutral |
| Momentum (10) | 0.18 | Buy |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 5.31 | Buy |
| ADX (14) | 15.35 | Neutral |
| ATR (14) | 0.22 | Info |
The 30-day technical picture is Neutral in sentiment. The RSI(14) is 50, and the stock trades below both the SMA50 and SMA200, with the SMA50 listed at $5.88 and the SMA200 at $7.59.
In the near term, the 30-day price range spans from $3.86 to $7.19, indicating meaningful volatility. The stock shows a defined support at $4.83 and a resistance at $6.08.
Annualized volatility is high at 90%, underscoring substantial near-term price swings around the current level of $5.27.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.74 | $5.43 | $7.22 | 0% | Neutral | |
| $5.48 | $7.34 | $10.56 | +35% | Bullish | |
| $6.09 | $8.56 | $13.03 | +58% | Bullish | |
| $5.78 | $8.48 | $13.48 | +56% | Bullish | |
| $5.10 | $7.77 | $12.79 | +43% | Bullish | |
| $5.39 | $8.50 | $14.45 | +57% | Bullish | |
| $5.68 | $9.26 | $16.17 | +70% | Bullish | |
| $6.79 | $11.43 | $20.46 | +110% | Bullish | |
| $7.81 | $13.56 | $24.82 | +150% | Bullish | |
| $7.12 | $12.73 | $23.79 | +134% | Bullish | |
| $10.21 | $21.00 | $42.78 | +287% | Bullish | |
| $12.85 | $28.55 | $65.67 | +426% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.74 | $5.43 | $6.80 | +0.00% |
| August 2026 | $4.53 | $5.44 | $6.78 | +0.17% |
| September 2026 | $4.47 | $5.43 | $6.89 | -0.14% |
| October 2026 | $4.66 | $5.73 | $7.38 | +5.45% |
| November 2026 | $4.59 | $5.69 | $7.42 | -0.67% |
| December 2026 | $4.38 | $5.47 | $7.22 | -3.81% |
Click any year to see its month-by-month CVRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The CVRX price prediction for 2026 points to an average of $5.43 (low $4.74, high $7.22) — a potential gain of 0% on today's $5.43. Price action looks broadly range-bound.
In 2027, CVRX is projected to trade between $5.48 and $10.56, averaging $7.34 — a potential gain of +35% from today's $5.43. That is up +35% on the projected 2026 average. Buyers look set to stay in control over this stretch.
CVRx, Inc.'s 2028 outlook centres on $8.56, within a $6.09 to $13.03 range. That is up +17% on the projected 2027 average. That marks a +58% change versus current levels. Momentum favours further upside here.
By 2029, CVRX could reach as high as $13.48, with a base case around $8.48 and support toward $5.78 — roughly +56% from $5.43. Buyers look set to stay in control over this stretch.
Expect CVRX to range from $5.10 to $12.79 through 2030. The $7.77 average target implies a +43% move from current prices. That is -8% versus the projected 2029 average. Momentum favours further upside here.
The CVRX price prediction for 2031 points to an average of $8.50 (low $5.39, high $14.45) — a potential gain of +57% on today's $5.43. Buyers look set to stay in control over this stretch.
In 2032, CVRX is projected to trade between $5.68 and $16.17, averaging $9.26 — a potential gain of +70% from today's $5.43. That is up +9% on the projected 2031 average. Momentum favours further upside here.
CVRx, Inc.'s 2033 outlook centres on $11.43, within a $6.79 to $20.46 range. That is up +23% on the projected 2032 average. That marks a +110% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, CVRX could reach as high as $24.82, with a base case around $13.56 and support toward $7.81 — roughly +150% from $5.43. Momentum favours further upside here.
Expect CVRX to range from $7.12 to $23.79 through 2035. The $12.73 average target implies a +134% move from current prices. That is -6% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
The CVRX price prediction for 2040 points to an average of $21.00 (low $10.21, high $42.78) — a potential gain of +287% on today's $5.43. Momentum favours further upside here.
In 2050, CVRX is projected to trade between $12.85 and $65.67, averaging $28.55 — a potential gain of +426% from today's $5.43. That is up +36% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CVRX today (≈ 184.162063 CVRX) could be worth
$5,258.49
+$4,258.49 (+426%) by 2050 · US Dollar
Based on the average projected CVRX price of $28.55 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CVRXwould be worth at today's price.
$1,000 invested in CVRX on Jul 10, 2025 (≈ 143.67816 CVRX) would be worth
$780.17
-$219.83 (-22.0%) today · 0.78× · US Dollar
Based on a CVRX entry price of $6.96 vs. today's $5.43.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.6 | $969.64 | -3.0% |
| 1 month ago | $4.83 | $1,124.22 | +12.4% |
| 3 months ago | $7.16 | $758.91 | -24.1% |
| 6 months ago | $7.31 | $742.82 | -25.7% |
| 1 year ago | $6.96 | $780.17 | -22.0% |
| All time (5.0y) ago | $20.1 | $270.15 | -73.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CVRX forecast.
Our base-case forecast reaches $11.00 around 2033.
Implied market cap at $11.00: $291.9M
The multi-year forecast paints a bullish path after 2026. The 2026 forecast yields a min of $4.74, an avg of $5.27, a max of $7.03, and a 0% ROI with neutral sentiment.
From 2027 onward, the forecasts turn increasingly bullish: 2027 avg $7.21 with ROI 36.8% and bullish sentiment; 2028 avg $8.35 (58.5%); 2029 avg $8.26 (56.7%); 2030 avg $7.55 (43.3%); 2031 avg $8.21 (55.8%); 2032 avg $8.96 (70.1%); 2033 avg $11.15 (111.6%); 2034 avg $13.21 (150.7%); 2035 avg $12.39 (135%).
The growth continues into the next decade with 2040 avg $20.48 (288.6%) and 2050 avg $27.52 (422.1%), both with bullish sentiment. These figures illustrate a substantial long-term upside but are, by nature, estimates and not guarantees; actual results will depend on factors affecting demand, approvals, competition, and market conditions.
Tap a question to reveal the answer.
The 2030 forecast shows min $4.89, avg $7.55, max $12.60, ROI 43.3%, sentiment bullish.
Forecasts indicate bullish sentiment from 2027 onward with rising averages and ROI up to 422.1% by 2050, but these are estimates and not guarantees.
Yes. The forecasted maxima include $10.47 in 2027, $12.60 in 2030, $14.14 in 2031, $15.88 in 2032, and higher values such as $20.26 in 2033, indicating potential to exceed $10 in multiple years.
Current price is $5.27, market cap is $139.84M, and rank is 4038, with sentimentNeutral.
Forecast for 2040 shows min $9.63, avg $20.48, max $42.46, ROI 288.6%, sentiment bullish.
CVRx, Inc. Community Discussion
0Share your CVRx, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.